跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAIN
Approved
STANDARD
ANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAIN
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
327f430816327bee
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
327f430816327bee
Product Name
ANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAIN
Artg Id
148975
Artg Name
ANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAIN
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2008-01-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
327f430816327bee
Type
Standard
Back to TGA Approvals
ANZATAX (Paclitaxel) Injection Concentrate 30 mg in 5 mL ONCO-TAIN - TGA Drug Approval Details
